New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia – Module – 2 – Enduring Webcast

Description

Program Description

---

This webcast is intended to improve care of patients with leukemia by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Intended Audience

---

This webcast is designed to meet the educational needs of hematologists/oncologists and other health care professionals who diagnose, treat, and manage patients leukemia. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity.

Commercial Supporter

---

Supported by Novartis Pharmaceuticals Corporation and Takeda Oncology